BioSpace News Archive

VBL Therapeutics (Nasdaq: VBLT) today announced that it has been awarded a non-dilutive grant of up to 3.175 million New Israeli Shekels (NIS) (approximately $0.9 million) by the Israel Innovation Authority (IIA). The IIA has approved a budget of approximately $1.8 million for the VB-111 project during 2020, with 50% of this amount as an IIA grant. The funds will support the continued development of VBL’s lead product candidate, VB-111, a fi

Cyclacel Pharmaceuticals, Inc. announced the pricing of a public offering with expected total gross proceeds of approximately $20 million, before deducting placement agent fees and other offering expenses payable by the Company.

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that on March 17, 2020 the United States Patent and Trademark Office issued Patent No. 10,588,927 B

ChromaCode joining fight against novel coronavirus; High-Definition PCR SARS-CoV-2 assay to increase test throughput and reduce complexity of interpretation

Decorated Healthcare Executive and Current CVS Health Director Brings Deep Expertise to Burgeoning Blood Testing Company

AIkido Pharma Inc. announced that on April 13, 2020, the Company executed a Master License Agreement with the University of Maryland, Baltimore.

The Population Health Research Institute and Bayer Inc. announced plans to immediately launch a major clinical research program aimed at identifying potential COVID-19 treatments.

Selexis SA, a JSR Life Sciences Company, announced that Great Place to Work® has recognized the Company as one of the “Best Workplaces in Switzerland 2020.” Selexis joins companies of all sizes from all industries whose employees think they have an especially trustworthy, appreciative and attractive workplace culture.

American Lung Association’s ‘State of the Air’ report finds climate change is driving increases in unhealthy air, 150 million people at risk

Group sales revenue up 16.5%; order intake up 29.7%; underlying EBITDA margin 27.0%